Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 137

Similar articles for PubMed (Select 22511602)

1.

Altered expression of key players in vitamin D metabolism and signaling in malignant and benign thyroid tumors.

Clinckspoor I, Hauben E, Verlinden L, Van den Bruel A, Vanwalleghem L, Vander Poorten V, Delaere P, Mathieu C, Verstuyf A, Decallonne B.

J Histochem Cytochem. 2012 Jul;60(7):502-11. doi: 10.1369/0022155412447296. Epub 2012 Apr 17.

2.

Impaired vitamin D activation and association with CYP24A1 haplotypes in differentiated thyroid carcinoma.

Penna-Martinez M, Ramos-Lopez E, Stern J, Kahles H, Hinsch N, Hansmann ML, Selkinski I, Grünwald F, Vorländer C, Bechstein WO, Zeuzem S, Holzer K, Badenhoop K.

Thyroid. 2012 Jul;22(7):709-16. doi: 10.1089/thy.2011.0330. Epub 2012 Jun 12.

3.

Vitamin D in thyroid tumorigenesis and development.

Clinckspoor I, Verlinden L, Mathieu C, Bouillon R, Verstuyf A, Decallonne B.

Prog Histochem Cytochem. 2013 Aug;48(2):65-98. doi: 10.1016/j.proghi.2013.07.001. Epub 2013 Jul 26. Review.

PMID:
23890557
4.

Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.

Chow EC, Quach HP, Vieth R, Pang KS.

Am J Physiol Endocrinol Metab. 2013 May 1;304(9):E977-89. doi: 10.1152/ajpendo.00489.2012. Epub 2013 Mar 12.

5.

Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.

Lopes N, Sousa B, Martins D, Gomes M, Vieira D, Veronese LA, Milanezi F, Paredes J, Costa JL, Schmitt F.

BMC Cancer. 2010 Sep 11;10:483. doi: 10.1186/1471-2407-10-483.

6.

Expressions of vitamin D metabolic components VDBP, CYP2R1, CYP27B1, CYP24A1, and VDR in placentas from normal and preeclamptic pregnancies.

Ma R, Gu Y, Zhao S, Sun J, Groome LJ, Wang Y.

Am J Physiol Endocrinol Metab. 2012 Oct 1;303(7):E928-35. doi: 10.1152/ajpendo.00279.2012. Epub 2012 Aug 7.

7.

Stress and vitamin D: altered vitamin D metabolism in both the hippocampus and myocardium of chronic unpredictable mild stress exposed rats.

Jiang P, Zhang WY, Li HD, Cai HL, Liu YP, Chen LY.

Psychoneuroendocrinology. 2013 Oct;38(10):2091-8. doi: 10.1016/j.psyneuen.2013.03.017. Epub 2013 Apr 20.

PMID:
23608137
8.

Expression of the vitamin D receptor, 25-hydroxylases, 1alpha-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer.

Blomberg Jensen M, Andersen CB, Nielsen JE, Bagi P, Jørgensen A, Juul A, Leffers H.

J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):376-82. doi: 10.1016/j.jsbmb.2010.03.069. Epub 2010 Apr 1.

PMID:
20362668
9.

Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue.

Epstein MM, Andrén O, Kasperzyk JL, Shui IM, Penney KL, Fall K, Rider JR, Stampfer MJ, Andersson SO, Giovannucci E, Mucci LA.

Cancer Causes Control. 2012 Aug;23(8):1359-66. doi: 10.1007/s10552-012-0016-9. Epub 2012 Jun 19.

10.

Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue.

Smolders J, Schuurman KG, van Strien ME, Melief J, Hendrickx D, Hol EM, van Eden C, Luchetti S, Huitinga I.

J Neuropathol Exp Neurol. 2013 Feb;72(2):91-105. doi: 10.1097/NEN.0b013e31827f4fcc.

PMID:
23334593
11.

25-hydroxyvitamin D3 1alpha-hydroxylase and vitamin D receptor expression in papillary thyroid carcinoma.

Khadzkou K, Buchwald P, Westin G, Dralle H, Akerström G, Hellman P.

J Histochem Cytochem. 2006 Mar;54(3):355-61. Epub 2005 Nov 28.

PMID:
16314444
12.

Vitamin D hydroxylases CYP2R1, CYP27B1 and CYP24A1 in renal cell carcinoma.

Urbschat A, Paulus P, von Quernheim QF, Brück P, Badenhoop K, Zeuzem S, Ramos-Lopez E.

Eur J Clin Invest. 2013 Dec;43(12):1282-90. doi: 10.1111/eci.12176. Epub 2013 Oct 12.

PMID:
24245571
13.

25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.

Segersten U, Holm PK, Björklund P, Hessman O, Nordgren H, Binderup L, Akerström G, Hellman P, Westin G.

Breast Cancer Res. 2005;7(6):R980-6. Epub 2005 Oct 6.

14.

A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on markers of their metabolism in normal mucosa of colorectal adenoma patients.

Ahearn TU, McCullough ML, Flanders WD, Long Q, Sidelnikov E, Fedirko V, Daniel CR, Rutherford RE, Shaukat A, Bostick RM.

Cancer Res. 2011 Jan 15;71(2):413-23. doi: 10.1158/0008-5472.CAN-10-1560. Epub 2010 Nov 17.

15.

Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D 1 alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers.

Agic A, Xu H, Altgassen C, Noack F, Wolfler MM, Diedrich K, Friedrich M, Taylor RN, Hornung D.

Reprod Sci. 2007 Jul;14(5):486-97.

PMID:
17913968
16.

Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk.

Dong LM, Ulrich CM, Hsu L, Duggan DJ, Benitez DS, White E, Slattery ML, Farin FM, Makar KW, Carlson CS, Caan BJ, Potter JD, Peters U.

Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2540-8. doi: 10.1158/1055-9965.EPI-09-0228. Epub 2009 Aug 25.

17.

Expression of VDR and CYP24A1 mRNA in human tumors.

Anderson MG, Nakane M, Ruan X, Kroeger PE, Wu-Wong JR.

Cancer Chemother Pharmacol. 2006 Jan;57(2):234-40. Epub 2005 Sep 23.

PMID:
16180015
19.

In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells.

Reichrath J, Rech M, Moeini M, Meese E, Tilgen W, Seifert M.

Cancer Biol Ther. 2007 Jan;6(1):48-55.

PMID:
17172823
20.

Vitamin D less-calcemic analog modulates the expression of estrogen receptors, vitamin D receptor and 1α-hydroxylase 25-hydroxy vitamin D in human thyroid cancer cell lines.

Somjen D, Grafi-Cohen M, Posner GH, Sharon O, Kraiem Z, Stern N.

J Steroid Biochem Mol Biol. 2013 Jul;136:80-2. doi: 10.1016/j.jsbmb.2012.09.015. Epub 2012 Oct 8. Review.

PMID:
23059472
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk